X0306 4 2019-03-05 0 0001466301 Clovis Oncology, Inc. CLVS 0001268304 IVERS-READ GILLIAN C C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY, SUITE 100 BOULDER CO 80301 0 1 0 0 See Remarks Common Stock 2019-03-05 4 M 0 625 A 187823 D Common Stock 2019-03-05 4 S 0 316 29.29 D 187507 D Common Stock 2019-03-05 4 M 0 2750 A 190257 D Common Stock 2019-03-05 4 S 0 1295 29.29 D 188962 D Restricted Stock Units 2019-03-05 4 M 0 625 0.00 D Common Stock 625 5000 D Restricted Stock Units 2019-03-05 4 M 0 2750 0.00 D Common Stock 2750 8250 D Each Restricted Stock Unit represents the right to receive one share of Common Stock. Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person. On March 27, 2017, the reporting person was granted 10,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date. On March 1, 2018, the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date. Executive Vice President of Technical Operations and Chief Regulatory Officer /s/ Gillian C. Ivers-Read 2019-03-06